Company Overview and News

9
D / Dominion Resources, Inc. 425 (Prospectus)

2018-07-17 sec.gov
425 Filed by Dominion Energy, Inc. (Commission File No. 1-8489) Pursuant to Rule 425 under the Securities Act of 1933
D

9
D / Dominion Resources, Inc. 425 (Prospectus)

2018-07-17 sec.gov
425 Filed by Dominion Energy, Inc. (Commission File No. 1-8489) Pursuant to Rule 425 under the Securities Act of 1933
D

9
D / Dominion Resources, Inc. 425 (Prospectus)

2018-07-16 sec.gov
425 Filed by Dominion Energy, Inc. (Commission File No. 1-8489) Pursuant to Rule 425 under the Securities Act of 1933
D

9
D / Dominion Resources, Inc. 425 (Prospectus)

2018-07-16 sec.gov
425 Filed by Dominion Energy, Inc. (Commission File No. 1-8489) Pursuant to Rule 425 under the Securities Act of 1933
D

9
D / Dominion Resources, Inc. 8-K (Prospectus)

2018-07-13 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
D

9
D / Dominion Resources, Inc. 8-K (Prospectus)

2018-07-13 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
D

9
D / Dominion Resources, Inc. 8-K (Current Report)

2018-07-13 sec.gov
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
D

9
D / Dominion Resources, Inc. 425 (Prospectus)

2018-07-13 sec.gov
425 Filed by Dominion Energy, Inc. (Commission File No. 1-8489) Pursuant to Rule 425 under the Securities Act of 1933 and
D

9
D / Dominion Resources, Inc. 425 (Prospectus)

2018-07-13 sec.gov
425 Filed by Dominion Energy, Inc. (Commission File No. 1-8489) Pursuant to Rule 425 under the Securities Act of 1933 and
D

22
Teekay Continues To Transition - What's The Timing?

2018-07-13 seekingalpha
Teekay Corporation has been one of my largest personal holdings, largely based upon their control of Teekay LNG Partners.
TOO TK D HMLP SSW GLOP.PRA GLOP.PRB GLOP GLNG AROC DLNG TGP.PRA TGP.PRB TGP GLOG KNOP DLNG.PRA GMLP DM NS HMLP.PRA

25
Watchlist July 2018

2018-07-12 seekingalpha
It's time for the monthly watchlist report. As always, you can find the updated info at any time here Dividend Income Spreadsheet and the Portfolio Spreadsheet.
SOJA SO ENB PM HRL D IDTVF SBUX ENB KMB MO

9
D / Dominion Resources, Inc. null

2018-07-11 sec.gov
begin 644 filename1.pdf M)5!$1BTQ+C4-)>+CS],-"C0V(# @;V)J#3P\+TQI;F5A
D

9
D / Dominion Resources, Inc. null

2018-07-11 sec.gov
CORRESP Dominion Energy, Inc. June 6, 2018 VIA EDGAR Division of Corporation Finance United States Securities and Exchange Commission
D

13
U.S. LNG Exports Part 1: Capacity Jumping In 2019, But Will There Be Enough?

2018-07-11 seekingalpha
Last year, the US was one of 19 countries exporting liquefied natural gas (LNG) and played a relatively small role in the global market. To be precise, LNG exports from the US represented just 5% (1.9 Bcf/d) of the 38.2 Bcf/d global LNG market. That said, the US is on the brink of adding significant LNG export capacity next year and becoming a sizable player in the global LNG market. As an indication of the rising significance of the US, the World Gas Conference was held in Washington, D.
D XOM KMI.WS ALJ SRE.PRA ALDW KMI.PRA KMI SRE TELL KMR KMRFZ CVB

9
Happy July Fourth, America! Celebrating The U.S. Energy Revolution

2018-07-04 seekingalpha
In just ten years, the US energy landscape has radically changed. Ten years ago, the headlines we take for granted today about record US oil production and energy independence would have been a pipe dream. In conjunction with tomorrow’s July Fourth holiday, we take the opportunity in today’s post to appreciate the positive progress in US energy over the last decade, comparing 2008 to 2018.
ETP ALDW D REX ALJ

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Silicon Investor Message Boards

This table lists all message boards related to D / Dominion Resources, Inc. on message board site Silicon Investor.

Laughter is the Best Medicine - Tell us a joke The Trump Presidency
Biotech Short Candidates Pennies Arent Dead
Formerly About Advanced Micro Devices NNVC - NanoViricides, Inc.
Politics for Pros- moderated View from the Center and Left
Da_cheifs vomitorium A Real American President: Donald Trump
CUSIP: 25746U109